I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 6 studies | 41% ± 22% | |
| retinal rod cell | 3 studies | 19% ± 2% | |
| GABAergic neuron | 3 studies | 42% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 6 studies | 41% ± 22% | |
| retinal rod cell | 3 studies | 19% ± 2% | |
| GABAergic neuron | 3 studies | 42% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 32% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 17079.93 | 2634 / 2642 | 100% | 56.18 | 702 / 705 |
| ovary | 99% | 3264.45 | 178 / 180 | 100% | 68.14 | 429 / 430 |
| pancreas | 100% | 3632.88 | 328 / 328 | 92% | 21.57 | 164 / 178 |
| thymus | 100% | 4327.27 | 651 / 653 | 92% | 26.43 | 558 / 605 |
| prostate | 97% | 2538.14 | 237 / 245 | 90% | 13.94 | 450 / 502 |
| lung | 96% | 2086.38 | 552 / 578 | 90% | 26.75 | 1041 / 1155 |
| stomach | 95% | 3224.79 | 340 / 359 | 90% | 28.59 | 258 / 286 |
| kidney | 100% | 4412.76 | 89 / 89 | 72% | 18.08 | 653 / 901 |
| intestine | 80% | 1253.86 | 770 / 966 | 88% | 25.43 | 466 / 527 |
| uterus | 92% | 1836.74 | 156 / 170 | 71% | 18.07 | 327 / 459 |
| bladder | 90% | 1546.29 | 19 / 21 | 70% | 16.00 | 352 / 504 |
| adrenal gland | 64% | 960.31 | 165 / 258 | 87% | 24.04 | 199 / 230 |
| esophagus | 55% | 845.63 | 796 / 1445 | 79% | 22.32 | 145 / 183 |
| breast | 62% | 1008.56 | 283 / 459 | 50% | 8.83 | 563 / 1118 |
| liver | 31% | 361.10 | 71 / 226 | 68% | 11.47 | 277 / 406 |
| heart | 85% | 1580.07 | 728 / 861 | 0% | 0 | 0 / 0 |
| skin | 26% | 323.68 | 471 / 1809 | 53% | 6.93 | 249 / 472 |
| muscle | 64% | 1211.59 | 512 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 61% | 8.96 | 49 / 80 |
| blood vessel | 56% | 797.80 | 753 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 7.18 | 18 / 45 |
| adipose | 34% | 408.65 | 413 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 9% | 99.89 | 21 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 3.83 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0061001 | Biological process | regulation of dendritic spine morphogenesis |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0045202 | Cellular component | synapse |
| GO_0043197 | Cellular component | dendritic spine |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005737 | Cellular component | cytoplasm |
| Gene name | LZTS3 |
| Protein name | Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1) (ProSAPiP1) |
| Synonyms | PROSAPIP1 KIAA0552 |
| Description | FUNCTION: May be involved in promoting the maturation of dendritic spines, probably via regulating SIPA1L1 levels at the postsynaptic density of synapses. . |
| Accessions | ENST00000329152.7 [O60299-1] ENST00000337576.7 [O60299-1] ENST00000360342.7 [O60299-2] O60299 ENST00000645462.1 [O60299-2] |
